FDA recall Z-0564-2022

E25Bio, Inc. · Class I · device

Product

E25Bio COVID-19 Direct Antigen Rapid Test ; E25Bio COVID-19 DART Kit

Reason for recall

The Test is not authorized, cleared, or approved by FDA for clinical diagnostic or screening purposes. It was distributed without sufficient directions or controls in place.

Distribution

US Nationwide distribution in the states of MA, FL, and HI.

Key facts

Status
Terminated
Initiation date
2022-01-27
Report date
2022-02-16
Termination date
2022-09-19
Voluntary/Mandated
Voluntary: Firm initiated
Location
Cambridge, MA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0564-2022